Category: Baird

  • Baird maintains Outperform rating on Costco shares on strong sales By Investing.com

    Baird reiterated an outperform rating on Costco Wholesale (NASDAQ: NASDAQ: ), while maintaining a price target of $975.00. Costco’s underlying global comparable sales, excluding gas and foreign exchange impacts, rose 8.9%, the company’s analysis highlighted. This increase includes an approximately 1.5% increase in storage activity that occurred in late September,…

  • Autodesk rises as Baird praises Q2 results, guidance (ADSK)

    JHVEphoto Autodesk (NASDAQ:ADSK) stocks Up 2% Friday after the architectural software company reported second-quarter results and guidance that investment firm Baird viewed as positive. “FY25 forecasts are on the upside, with greater contribution from the new transaction model (which includes updates to “Billings/revenues were largely in line with our expectations,”…

  • Baird cuts Albemarle stock rating amid lithium price concerns By Investing.com

    On Monday, financial services firm Bird downgraded its rating. Albemarle University Chemical Company (NYSE:), a chemical company specializing in lithium, bromine, and refining catalysts. The rating was downgraded to Neutral from Outperform, and the price target was revised to $85.00 from $102.00 previously. The revision reflects Baird’s view of the…

  • Apple rises as Baird bumps price target on AI opportunity (AAPL)

    unforgetable apple (NASDAQ:AAPLApple shares rose on Thursday after investment firm Baird raised its price target on the tech giant, citing an opportunity to boost iPhone sales due to an artificial intelligence initiative known as Apple Intelligence. We estimate that approximately 95% of “The iPhones globally, even with an initial focus…

  • Agenus stock cut at Baird on FDA feedback (NASDAQ:AGEN)

    George Clerc After falling nearly 60% in the previous session, Agenus shares (NASDAQ: Agen) Decreased by ~5% Shares of Baird fell Friday after the company downgraded its rating, citing FDA reactions to its colorectal cancer treatment combination BOT/BAL that led to selling. After meeting with Food and Drug Administration, Agnusan…